MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Association of Retinol Binding Protein (RBP) and the Risk of Parkinson’s disease (PD): A Narrative Literature Review

V. Sharma (Urban, India)

Meeting: 2024 International Congress

Abstract Number: 944

Keywords: Parkinson’s

Category: Parkinson's Disease: Molecular Mechanisms of Disease

Objective: This review aimed to investigate the association between RBP levels and the risk of Parkinson’s disease

Background: RBP facilitates retinol transport from the liver to peripheral organs to meet vitamin A requirements. Previous studies suggest a link of pathophysiology of various neurological disorders to vitamin A-related compounds

Method: A comprehensive search of electronic databases was conducted from date of inception till 13th March 2024. Inclusion criteria encompassed human studies in English reporting RBP and Parkinson’s disease. Data were manually extracted into an Excel spreadsheet. Results were presented as standard mean deviations and 95% CI

Results: Preliminary analysis revealed that only 2 studies were eligible for the review. Serum RBP levels were measured in both the studies compared to controls. Overall analysis demonstrated no statistically significant difference between serum RBP levels in PD patients compared to controls suggesting no association between serum RBP levels and increased risk of PD

Conclusion: Our findings suggest that serum concentrations of RBP, do not play a role in the pathogenesis of PD. But since there are only two studies, we cannot comment on whether RBP play a role in PD by potentially influencing retinol transport and metabolism or not. However, further studies are needed to validate these findings and elucidate the underlying mechanisms linking RBP to risk of PD

References: 1. Jiménez-Jiménez FJ, Molina JA, Fernández-Calle P, Vázquez A, Pondal M, del Ser T, Gómez-Pastor A, Codoceo R. Serum levels of vitamin A in Parkinson’s disease. J Neurol Sci. 1992 Aug;111(1):73-6. doi: 10.1016/0022-510x(92)90114-z. PMID: 1403000.
2. Durrieu G, LLau ME, Rascol O, Senard JM, Rascol A, Montastruc JL. Parkinson’s disease and weight loss: a study with anthropometric and nutritional assessment. Clin Auton Res. 1992 Jun;2(3):153-7. doi: 10.1007/BF01818955. PMID: 1498561.
3. Zhao Y, Li C, Zhou X. Transcriptomic Analysis of Porcine Granulosa Cells Overexpressing Retinol Binding Protein 4. Genes (Basel). 2019 Aug 13;10(8):615. doi: 10.3390/genes10080615. PMID: 31412686; PMCID: PMC6722559.

To cite this abstract in AMA style:

V. Sharma. Association of Retinol Binding Protein (RBP) and the Risk of Parkinson’s disease (PD): A Narrative Literature Review [abstract]. Mov Disord. 2024; 39 (suppl 1). https://www.mdsabstracts.org/abstract/association-of-retinol-binding-protein-rbp-and-the-risk-of-parkinsons-disease-pd-a-narrative-literature-review/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2024 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/association-of-retinol-binding-protein-rbp-and-the-risk-of-parkinsons-disease-pd-a-narrative-literature-review/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley